CSL Outgoing CEO Deposed By Lawyers In U.S. Plasma Price-Fixing Suit
This article was originally published in PharmAsia News
Executive Summary
CSL's outgoing CEO Brian McNamee has been deposed by attorneys in a U.S. class-action suit against the Australian government's vaccine maker allegedly involved in international price-fixing of blood plasma.